Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire
Article
Beyond Labels – Mental Health Language Decoded
Workers' Comp
News Release
Enlyte Drug Trends Report Indicates Significant Drop of Opioid Use in Comp
Overall opioid utilization down nearly 10%; sustained-release opioids drop by over 10% SAN DIEGO – April 30, 2024 – Effo
Workers' Comp
News Release
Enlyte and Mitchell Honored as American Business Awards® Winners
Recognition Marks Consecutive Years of Stevie Award-Winning Excellence
Workers' Comp
Article
The Artificial Intelligence Revolution
In the insurance industry, innovation isn't just a buzzword; it's a lifeline to the future.
Workers' Comp
White Paper
Strategies for Combating Mental Health Challenges in Injured Employees
A Guide for Carriers and Employers Are your employees struggling with mental health challenges?
Mitchell
Article
Current Used Vehicle Market Conditions: Q1 2024
February/March 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.